tbuckley/cabot-search huggingface dataset:
Diagnosing Primary HIV Infection
Journal: Annals of Internal Medicine (2001)

Summaries for Patients2 January 2001Diagnosing Primary HIV InfectionSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-134-1-200101020-00006 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail What is the problem and what is known about it so far?Primary HIV infection is the symptomatic illness that can occur shortly after a person becomes infected with the virus. Symptoms include fever, fatigue, sore throat, muscle aches, joint pains, and/or rash. Since symptoms such as these are commonly caused by other infections, and since HIV antibody tests do not become positive immediately after a person becomes infected, it can be difficult for doctors to diagnose primary HIV infection.Why did the researchers do this particular study?To determine the usefulness of various symptoms and tests in making an ... Author, Article, and Disclosure InformationAffiliations: The summary below is from the full report titled “Diagnosis of Primary HIV-1 Infection.” It is in the 2 January 2001 issue of Annals of Internal Medicine (volume 134, pages 25-29). The authors are ES Daar, S Little, J Pitt, J Santangelo, P Ho, N Harawa, P Kerndt, JV Giorgi, J Bai, P Gaut, DD Richman, S Mandel, and S Nichols, for the Los Angeles County Primary HIV Infection Recruitment Network.Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. Previousarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoDiagnosis of Primary HIV-1 Infection Eric S. Daar , Susan Little , Jacqui Pitt , Joanne Santangelo , Pauline Ho , Nina Harawa , Peter Kerndt , Janis V. Giorgi , Jiexin Bai , Paula Gaut , Douglas D. Richman , Susan Mandel , Stephen Nichols , and Metrics 2 January 2001Volume 134, Issue 1Page: I-68KeywordsAntigensArthralgiaFeversHIV infectionsHematologic testsPainPharyngitisRNARashesSweat ePublished: 2 January 2001 Issue Published: 2 January 2001 Copyright & PermissionsCopyright © 2001 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...
MEDICAL EDUCATION.
Journal: JAMA (1893)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Books In Brief
Journal: JAMA (1980)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Congenital Absence of the Ductus Deferens
Authors: Richard D. Amelar
Journal: JAMA (1970)

<h3>To the Editor.—</h3> It is the rule rather than the exception, as stated in the answer, to have a normal testicle associated with a congenital absence of the vas deferens on the same side, and to have bilateral normal testicles if the absence of the vas deferens is bilateral. The embryologic development of the testes is from the genital ridges on the medial aspect of the mesonephros, while the vas deferens has a different origin, from the mesonephric duct. If development is disturbed before the human embryo is at the 60 mm (13 weeks) stage, it is possible to have a fully developed testicle and globus major of the epididymis with an undeveloped vas deferens, seminal vesicle, and ejaculatory duct. If the mesonephric duct ceased development at a very early stage (four weeks) the ureteric bud would not develop and there would be an absence of the ureter and kidney
THE ATTEMPTED MURDER OF THE PRESIDENT.
Journal: JAMA (1901)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The Status of Health Assessment 1994
Authors: J. E. Ware
Journal: Annual Review of Public Health (1995)

General health status and a broader concept of quality of life are discussed and methods of widely used surveys are reviewed. A consensus regarding the inclusion of measures of physical, mental, social, and role functioning and general health perceptions is noted for comprehensive assessments of health. A schematic of relationships among condition-specific and generic measures is presented along with results expected for objective and subjective measures of physical and mental dimensions of health. Suggestions are offered for the labeling of disease-specific and generic measures and ways to avoid confounding of content. Applications of health surveys in general population monitoring, health policy evaluation, clinical trials of alternative treatments, monitoring and improving of health care outcomes, and in everyday clinical practice are exemplified and discussed. A unified measurement strategy is proposed and arguments in favor of standardizing the content of health surveys across applications are offered.
p53 Expression in B-Cell Chronic Lymphocytic Leukemia: A Marker of Disease Progression and Poor Prognosis
Authors: Iole Cordone, Serena Masi, Francesca Romana Mauro, Silvia Soddu, Ornella Morsilli, Tiziana Valentini, Maria Luce Vegna, Cesare Guglielmi, Francesca Mancini, Sonia Giuliacci, Ada Sacchi, Franco Mandelli, Robert Foa
Journal: Blood (1998)
A Better IgE Trap to Control Urticaria
Authors: David M. Center
Journal: New England Journal of Medicine (2019)

Chronic spontaneous urticaria is a benign disease with symptoms that adversely affect quality of life, such as disrupted sleep, distracting pruritus, and unsightly wheals.1 Spontaneous attacks without identifiable triggers render prevention impossible. As a result, the therapeutic goal is complete remission.2 Remission is important because it also eliminates the itch–scratch–dermatographism–itch feedback loop that can result in cutaneous scarring. Most patients have a response to escalating doses of nonsedating antihistamines at four times the recommended daily dose. For persistent hives, second-line therapy is omalizumab2; this means that treatment costs escalate, from generic antihistamines that cost $10 per month to a biologic . . .
Histopathological Changes in Methionine Excess
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Hormone replacement treatment
Authors: P. E Belchetz
Journal: BMJ (1989)

SIR,-Dr Paul Belchetz reviewed the advantages and risks of oestrogen replacement therapy and pointed to the advantages of percutaneous or subcutaneous routes of delivery.Even so, a casual reader could be forgiven for concluding that oral therapy with so called "natural oestrogens" is safe, but is it?These oestrogenic preparations are natural to horses rather than humans, and, furthermore, they undergo substantial change in the gut and liver before entering the systemic circulation.Can we really be reassured that oral oestrogens reduce the risk of cardiovascular morbidity?Unfortunately, in the published case-control and cohort studies comparison is not between like and like.Study groups invariably contain more health conscious women, at low risk from death from all causes other than suicide.2There are fewer smokers or obese or hypertensive women and their exercise and dietary habits are likely to be more favourable than those of the controls.Even so, the Framingham study showed an increase in cardiovascular morbidity.3This long running study included more older patients and should not be ignored.Why should oral oestrogens, given together with 12 days of progestogen, not carry similar risks to oral contraceptive steroids?Given the available alternatives, should we not be circumspect, especially for women judged to be at high risk?Nor should we underrate the potential for inducing breast cancer.Too few studies continued long enough to give meaningful results.The Louisville study, however, suggests an increasing risk when oestrogens are taken for more than 12 years and that the risk increases with duration of use.4This accords with what we know of the natural biology of the disease.All patients, especially those with a first degree family history, should know of this possible risk and cooperate with careful follow up examinations, including mammography.Anyone who is now more con- fused may find more help by reading Hunt et al.2
THE BACILLUS OF MEASLES.
Journal: JAMA (1892)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
A Practical Manual of Insanity. For the Student and General Practitioner.
Journal: JAMA (1902)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
The Effect of Anti-HIV Drugs on the Amount of HIV in Semen
Journal: Annals of Internal Medicine (2000)

Summaries for Patients15 August 2000The Effect of Anti-HIV Drugs on the Amount of HIV in SemenSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-133-4-200008150-00039 SectionsAboutFull Text ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail What is the problem and what is known about it so far?Human immunodeficiency virus (HIV) is the cause of AIDS, a potentially deadly illness that interferes with the ability to fight off infection and certain types of cancer. In persons with HIV infection, the virus is found in body fluids, including blood and semen. Sexual contact is the most common way people spread the infection. Although the ability of anti-HIV drugs to lower the amount of virus in the blood is well known, the effect of those drugs on the amount of virus in semen has not been extensively ... Author, Article, and Disclosure InformationAffiliations: The summary below is from the full report titled “Effect of Antiretroviral Therapy on HIV Shedding in Semen.” It is in the 15 August 2000 issue of Annals of Internal Medicine (volume 133, pages 280-284). The authors are P.F. Barroso, M. Schechter, P. Gupta, M.F. Melo, M. Vieira, F.C. Murta, Y. Souza, and L.H. Harrison.Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine. Previousarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoEffect of Antiretroviral Therapy on HIV Shedding in Semen Paulo F. Barroso , Mauro Schechter , Phalguni Gupta , Maria F. Melo , Marcello Vieira , Fernanda C. Murta , Yeda Souza , and Lee H. Harrison Metrics Cited byOlder Adults Vastly Overestimate Both HIV Acquisition Risk and HIV Prevalence in Rural South Africa 15 August 2000Volume 133, Issue 4Page: 280KeywordsAIDSAntiretroviral therapyBloodBody fluidsCancer immunotherapyDrugsHIVHIV infectionsHematologic testsSemen ePublished: 15 August 2000 Issue Published: 15 August 2000 Copyright & PermissionsCopyright © 2000 by American College of Physicians. All Rights Reserved.Loading ...
Multiple chemotherapeutic agents for Hodgkin disease. Comparison of three routines: a cooperative study by acute leukemia group B
Authors: L. Stutzman
Journal: JAMA (1973)

Two hundred forty-seven patients with disseminated Hodgkin disease were randomly treated with one of three intensive multiple-agent regimens. Partial or complete response rates of 90% were obtained with each routine. The "MOPP" regimen—mechlorethamine hydrochloride, vincristine sulfate (Oncovin), procarbazine hydrochloride, and prednisone—yielded the longest duration of response but also had the highest toxicity. There was no difference in survival rates among patients on the three routines. Major factors associated with good response were female sex and little or no prior therapy. Minor favorable factors were stage III disease, lack of systemic symptoms, former responsiveness to therapy, and age of less than 60 years. The simultaneous dosage routine was superior in both response rate and lessened toxicity compared to sequential usage of the same drugs with the same total dosage.
BRONCHOSINUSITIS DISEASE
Journal: JAMA (1929)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Asthma
Authors: William W. Busse, Robert F. Lemanske
Journal: New England Journal of Medicine (2001)

Asthma is a complex syndrome with many clinical phenotypes in both adults and children. Its major characteristics include a variable degree of airflow obstruction, bronchial hyperresponsiveness, and airway inflammation. For many patients, the disease has its roots in infancy, and both genetic factors (atopy)1,2 and environmental factors (viruses,3 allergens,4 and occupational exposures5) contribute to its inception and evolution. To comprehend the pathogenetic mechanisms underlying the many variants of asthma, it is essential to identify factors that initiate, intensify, and modulate the inflammatory response of the airway and to determine how these immunologic and biologic processes produce the characteristic . . .
Continuing Medical Education
Journal: JAMA (1964)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
THE PHYSIOLOGIC SIGNIFICANCE OF HUMAN MILK
Journal: JAMA (1920)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal